{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:12:00Z","timestamp":1790201520438,"version":"4.1.0"},"reference-count":103,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T00:00:00Z","timestamp":1639526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>The COVID-19 pandemic has highlighted genetic vaccination as a powerful and cost-effective tool to counteract infectious diseases. Invasive fungal infections (IFI) remain a major challenge among immune compromised patients, particularly those undergoing allogeneic hematopoietic bone marrow transplantation (HSCT) or solid organ transplant (SOT) both presenting high morbidity and mortality rates. Candidiasis and Aspergillosis are the major fungal infections among these patients and the failure of current antifungal therapies call for new therapeutic aids. Vaccination represents a valid alternative, and proof of concept of the efficacy of this approach has been provided at clinical level. This review will analyze current understanding of antifungal immunology, with a particular focus on genetic vaccination as a suitable strategy to counteract these diseases.<\/jats:p>","DOI":"10.3389\/fmicb.2021.789774","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T11:43:21Z","timestamp":1639568601000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Genetic Vaccination as a Flexible Tool to Overcome the Immunological Complexity of Invasive Fungal Infections"],"prefix":"10.3389","volume":"12","author":[{"given":"Laura","family":"Luberto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Neroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orietta","family":"Gandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersilia Vita","family":"Fiscarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Salvatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Roscilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41435-021-00136-6","article-title":"Gene therapy avenues and COVID-19 vaccines","volume":"22","author":"Abu Abed","year":"2021","journal-title":"Genes Immun."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/j.1567-1364.2010.00665.x","article-title":"Vaccines based on whole recombinant Saccharomyces cerevisiae cells","volume":"10","author":"Ardiani","year":"2010","journal-title":"FEMS Yeast Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.jcyt.2015.05.011","article-title":"Clinical-scale isolation of the total Aspergillus fumigatus-reactive T-helper cell repertoire for adoptive transfer","volume":"17","author":"Bacher","year":"2015","journal-title":"Cytotherapy"},{"key":"B4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.0105-2896.2004.00143.x","article-title":"Expression library immunization to discover and improve vaccine antigens","volume":"199","author":"Barry","year":"2004","journal-title":"Immunol. Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/377632a0","article-title":"Protection against mycoplasma infection using expression-library immunization","volume":"377","author":"Barry","year":"1995","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/ajt.15097","article-title":"Usefulness of a systematic approach at listing for vaccine prevention in solid organ transplant candidates","volume":"19","author":"Blanchard-Rohner","year":"2019","journal-title":"Am. J. Transp."},{"key":"B8","first-page":"71","article-title":"DNA immunization as an efficient strategy for vaccination","volume":"1","author":"Bolhassani","year":"2009","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/jof3040057","article-title":"Global and multi-national prevalence of fungal diseases-estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J. Fungi."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.4049\/jimmunol.0900961","article-title":"Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination","volume":"183","author":"Bozza","year":"2009","journal-title":"J. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/s1286-4579(02)00007-2","article-title":"Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants","volume":"4","author":"Bozza","year":"2002","journal-title":"Microbes. Infect."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1084\/jem.189.8.1207","article-title":"Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis","volume":"189","author":"Brandhorst","year":"1999","journal-title":"J. Exp. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1097\/INF.0000000000000909","article-title":"Interferon-gamma immunotherapy in a patient with refractory disseminated candidiasis","volume":"34","author":"Buddingh","year":"2015","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1016\/j.vaccine.2009.03.030","article-title":"Saccharomyces cerevisiae as a vaccine against coccidioidomycosis","volume":"27","author":"Capilla","year":"2009","journal-title":"Vaccine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/nrmicro3156","article-title":"Development of vaccines for Candida albicans: fighting a skilled transformer","volume":"11","author":"Cassone","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/jof2010006","article-title":"Proteomic analysis of pathogenic fungi reveals highly expressed conserved cell wall proteins","volume":"2","author":"Champer","year":"2016","journal-title":"J. Fungi."},{"key":"B17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/367425a0","article-title":"How B and T cells talk to each other","volume":"367","author":"Clark","year":"1994","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/s0923-2494(98)80765-7","article-title":"Protective immunity in coccidioidomycosis","volume":"149","author":"Cox","year":"1998","journal-title":"Res. Immunol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/jof5010002","article-title":"Paracoccidioidomycosis in Immunocompromised Patients: a literature review","volume":"5","author":"de Almeida","year":"2018","journal-title":"J. Fungi."},{"key":"B20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.micinf.2012.11.007","article-title":"DNA vaccine encoding peptide P10 against experimental paracoccidioidomycosis induces long-term protection in presence of regulatory T cells","volume":"15","author":"de Amorim","year":"2013","journal-title":"Microbes. Infect."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1016\/j.vaccine.2012.04.069","article-title":"A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models","volume":"30","author":"De Bernardis","year":"2012","journal-title":"Vaccine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4994","DOI":"10.1128\/IAI.66.10.4994-5000.1998","article-title":"Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans","volume":"66","author":"Decken","year":"1998","journal-title":"Infect. Immun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/0264-410x(95)00256-z","article-title":"Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model","volume":"14","author":"Devi","year":"1996","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1365-2249.1994.tb06093.x","article-title":"Combined effect of fluconazole and thymosin alpha 1 on systemic candidiasis in mice immunosuppressed by morphine treatments","volume":"97","author":"di Francesco","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1128\/IAI.01311-10","article-title":"CD4+ T cells mediate the protective effect of the recombinant Asp f3-based anti-aspergillosis vaccine","volume":"79","author":"Diaz-Arevalo","year":"2011","journal-title":"Infect. Immun."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00299","article-title":"Protective effector cells of the recombinant asp f3 anti-aspergillosis vaccine","volume":"3","author":"Diaz-Arevalo","year":"2012","journal-title":"Front. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1099\/jmm.0.041665-0","article-title":"Fungal cell wall vaccines: an update","volume":"61","author":"Edwards","year":"2012","journal-title":"J. Med. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1196\/annals.1321.010","article-title":"Glucocorticoids and the Th1\/Th2 balance","volume":"1024","author":"Elenkov","year":"2004","journal-title":"Ann. NY Acad. Sci."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00272","article-title":"First line of defense: innate cell-mediated control of pulmonary aspergillosis","volume":"7","author":"Espinosa","year":"2016","journal-title":"Front. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00354","article-title":"Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants","volume":"4","author":"Flingai","year":"2013","journal-title":"Front. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1086\/496991","article-title":"Coccidioidomycosis","volume":"41","author":"Galgiani","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/1469-0691.12660","article-title":"Invasive fungal infections in solid organ transplant recipients","volume":"20","author":"Gavald\u00e0","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10020236","article-title":"Pneumocystis pneumonia: immunity, vaccines, and treatments","volume":"10","author":"Gingerich","year":"2021","journal-title":"Pathogens"},{"key":"B34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1146\/annurev.immunol.16.1.111","article-title":"CD40 and CD154 in cell-mediated immunity","volume":"16","author":"Grewal","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"B35","first-page":"2415","article-title":"Vaccination of cattle against ringworm caused by Trichophyton verrucosum","volume":"47","author":"Gudding","year":"1986","journal-title":"Am. J. Vet. Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.4161\/hv.21838","article-title":"Universal fungal vaccines: could there be light at the end of the tunnel?","volume":"8","author":"Hamad","year":"2012","journal-title":"Hum. Vaccin. Immunother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1128\/CMR.9.4.469","article-title":"Virulence factors of medically important fungi","volume":"9","author":"Hogan","year":"1996","journal-title":"Clin. Microbiol. Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1086\/342509","article-title":"Vaccination of corticosteroid immunosuppressed mice against invasive pulmonary aspergillosis","volume":"186","author":"Ito","year":"2002","journal-title":"J. Infect. Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"S394","DOI":"10.1080\/13693780802552614","article-title":"Vaccine progress","volume":"47","author":"Ito","year":"2009","journal-title":"Med. Mycol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.1128\/IAI.00815-06","article-title":"Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis","volume":"74","author":"Ito","year":"2006","journal-title":"Infect. Immun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1016\/S0264-410X(03)00485-7","article-title":"Identification of a protective antigen of Coccidioides immitis by expression library immunization","volume":"21","author":"Ivey","year":"2003","journal-title":"Vaccine"},{"key":"B42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4314\/ajcem.v18i1.8","article-title":"A review of the virulence factors of pathogenic fungi","volume":"18","author":"Iyalla","year":"2017","journal-title":"African J. Clin. Exp. Microbiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1128\/IAI.67.11.5848-5853.1999","article-title":"Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis","volume":"67","author":"Jiang","year":"","journal-title":"Infect. Immun."},{"key":"B44","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1128\/IAI.67.2.630-635.1999","article-title":"Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA","volume":"67","author":"Jiang","year":"","journal-title":"Infect. Immun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1128\/IAI.71.1.47-60.2003","article-title":"Diversity at the locus associated with transcription of a variable surface antigen of Pneumocystis carinii as an index of population structure and dynamics in infected rats","volume":"71","author":"Keely","year":"2003","journal-title":"Infect. Immun."},{"key":"B46","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.4049\/jimmunol.162.5.2890","article-title":"IFN-gamma and CD8+ T cells restore host defenses against Pneumocystis carinii in mice depleted of CD4+ T cells","volume":"162","author":"Kolls","year":"1999","journal-title":"J. Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the transplant-associated infection surveillance network (TRANSNET) database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"10660","DOI":"10.1073\/pnas.1312789111","article-title":"Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection","volume":"111","author":"Kumaresan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B49","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"B50","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1128\/AAC.49.3.952-958.2005","article-title":"Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis","volume":"49","author":"Larsen","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1439-0507.2009.01691.x","article-title":"The changing face of epidemiology of invasive fungal disease in Europe","volume":"52","author":"Lass-Fl\u00f6rl","year":"2009","journal-title":"Mycoses"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.vaccine.2010.12.119","article-title":"Immune responses induced by heat killed Saccharomyces cerevisiae: a vaccine against fungal infection","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1128\/AAC.00220-06","article-title":"Peptide immunization as an adjuvant to chemotherapy in mice challenged intratracheally with virulent yeast cells of Paracoccidioides brasiliensis","volume":"50","author":"Marques","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"B54","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1182\/blood-2002-05-1496","article-title":"Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors","volume":"100","author":"Marr","year":"2002","journal-title":"Blood"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.4049\/jimmunol.172.2.1132","article-title":"T cytotoxic-1 CD8+ T cells are effector cells against pneumocystis in mice","volume":"172","author":"McAllister","year":"2004","journal-title":"J. Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1093\/mmy\/myy095","article-title":"Update on the Epidemiology of coccidioidomycosis in the United States","volume":"57","author":"McCotter","year":"2019","journal-title":"Med. Mycol."},{"key":"B57","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.4049\/jimmunol.162.3.1633","article-title":"Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis","volume":"162","author":"Mehrad","year":"1999","journal-title":"J. Immunol."},{"key":"B58","first-page":"1359","article-title":"Interferon gamma in association with immunosuppressive drugs withdrawal and antifungal combination as a rescue therapy for cerebral invasive Aspergillosis in a liver transplant recipient","volume":"80","author":"Mezidi","year":"2014","journal-title":"Minerva. Anestesiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.3201\/eid1010.030985","article-title":"Current epidemiology of Pneumocystis pneumonia","volume":"10","author":"Morris","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1128\/IAI.66.6.2640-2647.1998","article-title":"Interleukin-15 activates proinflammatory and antimicrobial functions in polymorphonuclear cells","volume":"66","author":"Musso","year":"1998","journal-title":"Infect. Immun."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/infdis\/172.6.1554","article-title":"Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis","volume":"172","author":"Nagai","year":"1995","journal-title":"J. Infect. Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.biopha.2018.10.075","article-title":"Fungal vaccines, mechanism of actions and immunology: A comprehensive review","volume":"109","author":"Nami","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110550","article-title":"Immune defence to invasive fungal infections: A comprehensive review","volume":"130","author":"Pathakumari","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B64","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1182\/blood-2005-05-1775","article-title":"Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation","volume":"106","author":"Perruccio","year":"2005","journal-title":"Blood"},{"key":"B65","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.idc.2010.01.002","article-title":"Fungal infections in transplant and oncology patients","volume":"24","author":"Person","year":"2010","journal-title":"Infect. Dis. Clin. North Am."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0050064","article-title":"Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells","volume":"5","author":"Phan","year":"2007","journal-title":"PLoS Biol."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.25424.1","article-title":"Advances in understanding the evolution of fungal genome architecture","volume":"9","author":"Priest","year":"2020","journal-title":"F1000Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.1128\/IAI.00278-07","article-title":"An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo.","volume":"75","author":"Rachini","year":"2007","journal-title":"Infect. Immun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.chom.2011.04.007","article-title":"A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus","volume":"9","author":"Ramirez-Ortiz","year":"2011","journal-title":"Cell Host Microbe."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.FUNK-0002-2016","article-title":"Antifungal drugs: the current armamentarium and development of new agents","volume":"4","author":"Robbins","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"B71","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1128\/CMR.10.4.611","article-title":"Interleukin-12 in infectious diseases","volume":"10","author":"Romani","year":"1997","journal-title":"Clin. Microbiol. Rev."},{"key":"B72","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000342121","article-title":"Granulocyte macrophage colony-stimulating factor in 66 patients with myeloid or lymphoid neoplasms and recipients of hematopoietic stem cell transplantation with invasive fungal disease","volume":"129","author":"Safdar","year":"2013","journal-title":"Acta Haematol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.humimm.2006.10.011","article-title":"Variable number of tandem repeats of TNF receptor type 2 promoter as genetic biomarker of susceptibility to develop invasive pulmonary aspergillosis","volume":"68","author":"Sainz","year":"2007","journal-title":"Hum. Immunol."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01612","article-title":"Immunomodulation as therapy for fungal infection: are we closer?","volume":"9","author":"Sam","year":"2018","journal-title":"Front. Microbiol."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019711","article-title":"Fungal vaccines and immunotherapeutics","volume":"4","author":"Santos","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.1016\/j.vaccine.2012.10.038","article-title":"NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults","volume":"30","author":"Schmidt","year":"2012","journal-title":"Vaccine"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2016.14281","article-title":"Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia","volume":"146","author":"Schmiedel","year":"2016","journal-title":"Swiss. Med. Wkly"},{"key":"B78","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mib.2017.10.018","article-title":"Modulating host immune responses to fight invasive fungal infections","volume":"40","author":"Scriven","year":"2017","journal-title":"Curr. Opin. Microbiol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/bmt.2008.237","article-title":"Randomized phase III study of granulocyte transfusions in neutropenic patients","volume":"42","author":"Seidel","year":"2008","journal-title":"Bone Marrow Transp."},{"key":"B80","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1046\/j.1440-1711.2001.01044.x","article-title":"DNA vaccines: future strategies and relevance to intracellular pathogens","volume":"79","author":"Sharma","year":"2001","journal-title":"Immunol. Cell Biol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4265\/bio.19.51","article-title":"Evaluation of Mdh1 protein as an antigenic candidate for a vaccine against candidiasis","volume":"19","author":"Shibasaki","year":"2014","journal-title":"Biocontrol Sci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41565-020-0737-y","article-title":"COVID-19 vaccine development and a potential nanomaterial path forward","volume":"15","author":"Shin","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11046-007-9071-2","article-title":"Insights into the pathobiology of Paracoccidioides brasiliensis from transcriptome analysis: advances and perspectives","volume":"165","author":"Silva","year":"2008","journal-title":"Mycopathologia"},{"key":"B84","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1128\/IAI.00700-08","article-title":"The antifungal vaccine derived from the recombinant N Terminus of Als3p protects mice against the bacterium staphylococcus aureus","volume":"76","author":"Spellberg","year":"2008","journal-title":"Infect. Immun."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/infdis\/jix469","article-title":"Aspergillus fumigatus cell wall \u03b1-(1,3)-Glucan stimulates regulatory T-Cell Polarization by inducing PD-L1 expression on human dendritic cells","volume":"216","author":"Stephen-Victor","year":"2017","journal-title":"J. Infect. Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"5881","DOI":"10.1182\/blood-2010-12-325084","article-title":"Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans","volume":"117","author":"Stuehler","year":"2011","journal-title":"Blood"},{"key":"B87","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/infdis\/jiv143","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation and association with occurrence and outcome of invasive aspergillosis","volume":"212","author":"Stuehler","year":"2015","journal-title":"J. Infect. Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1128\/IAI.66.2.786-793.1998","article-title":"Mapping of the T-cell epitope in the major 43-kilodalton glycoprotein of Paracoccidioides brasiliensis which induces a Th-1 response protective against fungal infection in BALB\/c mice","volume":"66","author":"Taborda","year":"1998","journal-title":"Infect. Immun."},{"key":"B89","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1590\/S0036-46652015000700005","article-title":"Paracoccidioidomycosis: Challenges in the development of vaccine against an endemic mycosis in the Americas","volume":"57","author":"Taborda","year":"2015","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"B90","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20050749","article-title":"A novel glyco-conjugate vaccine against fungal pathogens","volume":"202","author":"Torosantucci","year":"2005","journal-title":"J. Exp. Med."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005392","article-title":"Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence","volume":"4","author":"Torosantucci","year":"2009","journal-title":"PLoS One"},{"key":"B92","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1080\/14787210.2016.1199272","article-title":"Antifungal agents and liver toxicity: a complex interaction","volume":"14","author":"Tverdek","year":"2016","journal-title":"Expert. Rev. Anti Infect. Ther."},{"key":"B93","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1365-2567.2004.01819.x","article-title":"Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2","volume":"111","author":"Vilanova","year":"2004","journal-title":"Immunology"},{"key":"B94","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/infdis\/jit574","article-title":"Human natural killer cells acting as phagocytes against Candida albicans and mounting an inflammatory response that modulates neutrophil antifungal activity","volume":"209","author":"Voigt","year":"2014","journal-title":"J. Infect. Dis."},{"key":"B95","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1200\/JCO.2014.60.5121","article-title":"Effect of granulocyte-macrophage colony-stimulating factor on prevention and treatment of invasive fungal disease in recipients of allogeneic stem-cell transplantation: a prospective multicenter randomized phase IV trial.","volume":"33","author":"Wan","year":"2015","journal-title":"JCO"},{"key":"B96","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/IDR.S124918","article-title":"Antifungal resistance: current trends and future strategies to combat","volume":"10","author":"Wiederhold","year":"2017","journal-title":"Infect. Drug Resist."},{"key":"B97","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1086\/377099","article-title":"Selective effects of interleukin (IL)-15 on antifungal activity and IL-8 release by polymorphonuclear leukocytes in response to hyphae of Aspergillus species","volume":"188","author":"Winn","year":"2003","journal-title":"J. Infect. Dis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1128\/CVI.00036-11","article-title":"Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice","volume":"18","author":"Wozniak","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1172\/JCI11037","article-title":"Mutation of the WI-1 gene yields an attenuated blastomyces dermatitidis strain that induces host resistance","volume":"106","author":"W\u00fcthrich","year":"2000","journal-title":"J. Clin. Invest."},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035106","article-title":"Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis","volume":"7","author":"Xin","year":"2012","journal-title":"PLoS One"},{"key":"B101","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1128\/IAI.00459-09","article-title":"A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB\/c mice against coccidioidomycosis","volume":"77","author":"Xue","year":"2009","journal-title":"Infect. Immun."},{"key":"B102","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3904\/kjim.2013.28.4.403","article-title":"Vaccines against Coccidioides","volume":"28","author":"Yoon","year":"2013","journal-title":"Korean J. Intern. Med"},{"key":"B103","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1172\/JCI26306","article-title":"CD4+ T cell\u2013independent DNA vaccination against opportunistic infections","volume":"115","author":"Zheng","year":"2005","journal-title":"J. Clin. Invest."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.789774\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T15:45:29Z","timestamp":1674056729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.789774\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,15]]},"references-count":103,"alternative-id":["10.3389\/fmicb.2021.789774"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2021.789774","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,15]]},"article-number":"789774"}}